Understanding how messenger RNA binding proteins regulate gene expression

Regulation of mRNA Fate

NIH-funded research University of California Santa Cruz · NIH-10842838

This study is looking at how certain proteins that bind to messenger RNA can change the way genes are expressed and proteins are made, using special cell lines from humans and chimpanzees to understand these processes better.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of California Santa Cruz NIH-funded
Lab location1 site (Santa Cruz, United States)
Project IDNIH-10842838 on NIH RePORTER

What this research studies

This research investigates the roles of messenger RNA binding proteins (mRBPs) in controlling alternative splicing and mRNA translation. By utilizing genomics, molecular biology, and biochemistry, the team aims to uncover how specific RNA sequences influence gene expression and protein synthesis. The study will employ innovative cell lines that incorporate human and chimpanzee chromosomes to identify genetic variations that affect gene expression. This approach will help clarify the mechanisms by which alternative splicing impacts the stability and translation of mRNA.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals with genetic disorders influenced by mRNA processing, such as cystic fibrosis or certain cancers.

Not a fit: Patients with conditions unrelated to mRNA regulation or those not affected by alternative splicing may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new insights into gene regulation that may improve treatments for various genetic disorders and cancers.

How similar studies have performed: Previous research has shown promising results in understanding mRNA regulation, indicating that this approach could yield valuable insights.

Where this research is happening

Santa Cruz, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Aran-Duchenne diseaseCancers
Last reviewed 2026-06-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.